XORTX THERAPEUTICS INC(NASDAQ:XRTX) stock News

XRTX Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Benzinga - Mentions: DRIO MTNB CTMX ORGO ...

12 Health Care Stocks Moving In Thursday's After-Market Session

a month ago - By: Benzinga - Mentions: RNA KZIA APM RVMD ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

a month ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10

a month ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Initiates IND Preparation for XORLO™ in Gout Program

2 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Completes USD $114,500 Private Placement

3 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Completes Non-Brokered Private Placement of Units

5 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces USD $3 Million Offering

9 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX to Present at Microcap Conference

4 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces USD $925,000 Private Placement

6 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

7 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Update for Discussion with the FDA

9 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Change of Auditor

10 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Strengthens Executive Team

a year ago - By: BusinessInsider

XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q2 2024

8 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Commences Gout Program NDA Discussions with the FDA

10 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Presentation at the Rare and Genetic Disease Summit

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

a year ago - By: InvestorPlace

XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q2 2024

a year ago - By: InvestorPlace

XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q1 2024

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Initiates Precision Medicine Program

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Results of Annual and Special Meeting of Shareholders

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX to Present at BIO International Convention 2024

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

1 years ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Publication of Key Research in ADPKD

2 years ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Welcomes New Member to the Board of Directors

2 years ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX THERAPEUTICS INC (XRTX) Stock News

XRTX Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10

XORTX Initiates IND Preparation for XORLO™ in Gout Program

XORTX Completes USD $114,500 Private Placement

XORTX Completes Non-Brokered Private Placement of Units

XORTX Announces USD $3 Million Offering

XORTX to Present at Microcap Conference

XORTX Announces USD $925,000 Private Placement

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces Update for Discussion with the FDA

XORTX Announces Change of Auditor

XORTX Strengthens Executive Team

XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q2 2024

XORTX Commences Gout Program NDA Discussions with the FDA

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q2 2024

XRTX Stock Earnings: XORTX Therapeutics Reported Results for Q1 2024

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

XORTX to Present at BIO International Convention 2024

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Announces Publication of Key Research in ADPKD

XORTX Welcomes New Member to the Board of Directors

XORTX Announces New Clinical Advisory Board Member